ACTA1 and carcinoma: Evaluation of α-SMA, a marker of carcinoma-associated fibroblasts (CAFs), which are myofibroblasts constituting the cancer stroma with tumor-promoting potential, was positive in 10 cases (27%) (Fig. 3a).